Capital Fund Management (CFM)
AZN icon

Capital Fund Management (CFM)’s AstraZeneca AZN Stock Holding History

Capital Fund Management (CFM)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.28M Buy
36,900
+21,700
+143% +$4.18M 0.03% 710
2025
Q4 		$2.79M Buy
15,200
+1,950
+15% +$342K 0.01% 1530
2025
Q3 		$2.03M Buy
+13,250
New +$2.01M 0.01% 1783
2025
Q2 		– Sell
-16,400
Closed -$2.41M – 2333
2025
Q1 		$2.41M Sell
16,400
-6,450
-28% -$933K 0.01% 1329
2024
Q4 		$2.99M Buy
22,850
+10,350
+83% +$1.45M 0.01% 1330
2024
Q3 		$1.95M Buy
+12,500
New +$2.02M 0.01% 1446
2023
Q4 		– Sell
-10,350
Closed -$1.4M – 2098
2023
Q3 		$1.4M Buy
10,350
+1,700
+20% +$232K ﹤0.01% 1514
2023
Q2 		$1.24M Sell
8,650
-9,000
-51% -$1.32M 0.01% 1341
2023
Q1 		$2.45M Sell
17,650
-4,200
-19% -$565K 0.01% 997
2022
Q4 		$2.96M Sell
21,850
-27,300
-56% -$3.42M 0.02% 807
2022
Q3 		$5.39M Buy
49,150
+16,900
+52% +$2.14M 0.04% 523
2022
Q2 		$4.26M Buy
32,250
+24,800
+333% +$3.25M 0.04% 556
2022
Q1 		$988K Buy
+7,450
New +$893K 0.01% 1156
2020
Q2 		– Sell
-2,700
Closed -$241K – 1041
2020
Q1 		$241K Sell
2,700
-1,000
-27% -$94.1K ﹤0.01% 1323
2019
Q4 		$369K Buy
+3,700
New +$348K ﹤0.01% 1521
2015
Q1 		– Sell
-14,100
Closed -$992K – 1426
2014
Q4 		$992K Sell
14,100
-2,800
-17% -$200K 0.01% 888
2014
Q3 		$1.21M Sell
16,900
-39,200
-70% -$2.87M 0.01% 859
2014
Q2 		$4.17M Buy
56,100
+12,300
+28% +$889K 0.04% 476
2014
Q1 		$2.84M Buy
43,800
+12,800
+41% +$827K 0.03% 548
2013
Q4 		$1.84M Buy
31,000
+12,700
+69% +$690K 0.02% 731
2013
Q3 		$950K Buy
+18,300
New +$919K 0.01% 894

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Capital Fund Management (CFM)'s AZN Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in AstraZeneca (AZN) in Q1 2026: 51,161 shares worth $10.1M. The stake represents 0.05% of the portfolio and ranks #552 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in AZN as recently as Q2 2025.

Capital Fund Management (CFM) first reported a position in AZN in Q2 2013 and has held it in 22 quarters since. The position peaked at $40.3M in Q4 2023. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Capital Fund Management (CFM) held 51,161 shares of AstraZeneca worth $10.1M as of Q1 2026.
  • AstraZeneca was a new Capital Fund Management (CFM) position in Q1 2026.
  • AstraZeneca made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #552 holding.
  • Capital Fund Management (CFM) first reported a position in AstraZeneca in Q2 2013 and has held it in 22 quarters since.
  • Capital Fund Management (CFM)'s AstraZeneca position peaked at $40.3M in Q4 2023.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.